삼성서울병원

Ko En

Pathology Ko, Young Hyeh M.D

TITLE
Treament Schedule 02 月
날짜 01 02 03 04 05 06 07 08 09 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29
오전
오후
Treament Schedule 03 月
날짜 01 02 03 04 05 06 07 08 09 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31
오전
오후

Medical School

Specialty Training

Residency   
Internship   

Other Education

Specialty Interests

Participation in Academic Societies
and Research

Thesis

  • Ann Surg Oncol. 2017 Jun;24(6):1698-1706. doi: 10.1245/s10434-016-5497-4. Epub 2016 Aug 12. Differential Impact of Close Surgical Margin on Local Recurrence According to Primary Tumor Size in Oral Squamous Cell Carcinoma Jang JY11, Choi N2, Ko YH3, Chung MK2, Son YI2, Baek CH2, Baek KH4, Jeong HS5.
    View PubMed
  • Oncotarget. 2017 Apr 11;8(15):24621-24634. doi: 10.18632/oncotarget.15600. LMP1(+)SLAMF1(high) cells are associated with drug resistance in Epstein-Barr virus-positive Farage cells Yoon H11, Ko YH2.
    View PubMed
  • Oncotarget. 2017 Mar 28;8(13):22014-22022. doi: 10.18632/oncotarget.15782. Cell-of-origin of diffuse large B-cell lymphomas determined by the Lymph2Cx assay: better prognostic indicator than Hans algorithm Yoon N11, Ahn S2, Yong Yoo H3, Jin Kim S4, Seog Kim W4, Hyeh Ko Y5.
    View PubMed
  • Oncotarget. 2017 Mar 28;8(13):20645-20655. doi: 10.18632/oncotarget.15830. Axl acts as a tumor suppressor by regulating LIGHT expression in T lymphoma Lee EH11, Kim EM2, Ji KY3, Park AR3, Choi HR4, Lee HY5, Kim SM3, Chung BY1, Park CH1, Choi HJ1, Ko YH6, Bai HW1, Kang HS3.
    View PubMed
  • Am J Surg Pathol. 2017 Mar;41(3):299-312. doi: 10.1097/PAS.0000000000000775. Fibrin-associated EBV-positive Large B-Cell Lymphoma An Indolent Neoplasm With Features Distinct From Diffuse Large B-Cell Lymphoma Associated With Chronic Inflammation Boyer DF11, McKelvie PA, de Leval L, Edlefsen KL, Ko YH, Aberman ZA, Kovach AE, Masih A, Nishino HT, Weiss LM, Meeker AK, Nardi V, Palisoc M, Shao L, Pittaluga S, Ferry JA, Harris NL, Sohani AR.
    View PubMed